Alpha Cognition Inc (ACOG.US)

10-Year Study

ACOG.US · Healthcare · Common Stock

About Alpha Cognition Inc (ACOG.US)

Healthcare

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease....

Source: EODHD Financial Datasets
Fundamentals updated: Sep 13, 2026

Fundamental Snapshot

Alpha Cognition Inc (ACOG.US) reports a gross margin of 90.4% and an operating margin of -127.3%. Revenue changed +267.6% year-over-year while EPS changed +38.5%. Financially, its return on equity is -49.5%, current ratio stands at 9.03x.

Executive Summary: Alpha Cognition Inc has compounded at 16.2% annually over the last 10 years, with a maximum drawdown of 48.1% and an annualized volatility of 206.7%.

1Y CAGRCAGRCompound Annual Growth Rate — the annualized rate of return over a period, accounting for compounding.Click for full definition →
+45.1%
3Y CAGRCAGRCompound Annual Growth Rate — the annualized rate of return over a period, accounting for compounding.Click for full definition →
+16.2%
5Y CAGRCAGRCompound Annual Growth Rate — the annualized rate of return over a period, accounting for compounding.Click for full definition →
+16.2%
10Y CAGRCAGRCompound Annual Growth Rate — the annualized rate of return over a period, accounting for compounding.Click for full definition →
+16.2%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

View full price history data
DateValue
2024-11-01$10,000
2024-12-01$8,897
2025-01-01$8,640
2025-02-01$9,079
2025-03-01$7,644
2025-04-01$8,338
2025-05-01$14,094
2025-06-01$14,094
2025-07-01$13,761
2025-08-01$12,538
2025-09-01$9,834
2025-10-01$9,350
2025-11-01$9,094
2025-12-01$9,819
2026-01-01$7,311
2026-02-01$9,063
2026-03-01$8,293
2026-04-01$9,018
2026-05-01$9,350
2026-06-01$10,906
2026-07-01$12,508
2026-08-01$14,003
2026-09-01$13,157
Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
48.1%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.51
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
1.25
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
66.7%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · +34.0%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · 10.4%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
100%

Annual Returns

View full annual returns data
YearReturn
202510.4%
202634.0%

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-25.524.0-8.58.73.716.614.712.0-6.034.0%
2025-2.95.1-15.89.169.00.0-2.4-8.9-21.6-4.9-2.78.010.4%
2024-11.0-11.0%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
206.7%
View full factor risk breakdown
FactorRisk Exposure
VTI.US-18.7%
VEA.US-6.2%
VWO.US0.3%
QQQ.US4.4%
VTV.US8.4%
IJR.US-8.1%
QUAL.US23.5%
SHV.US7.8%
TLT.US-3.6%
LQD.US12.1%
HYG.US58.7%
GLD.US-0.7%
USO.US0.2%
VNQ.US9.4%
BTC-USD.CC6.0%
CPER.US0.5%
VIX.INDX-0.5%
UUP.US3.0%
TIP.US0.5%
Idiosyncratic2.8%

Alpha Cognition Inc Business Fundamentals

Reported valuation multiples, trailing margins, YoY growth, and balance-sheet liquidity.

Valuation Multiples

Grade: C
Forward P/E
26.88x
Moderately Elevated
Price-to-Sales (P/S)
12.70x
77th pct of 238 Healthcare peers · median 2.71x
Price-to-Book (P/B)
3.68x
52nd pct of 242 Healthcare peers · median 3.47x

Profitability & Margins

Gross Margin (TTM)
90.4%
89th pct of 195 Healthcare peers · median 57.5%
Operating Margin (TTM)
-127.3%
15th pct of 224 Healthcare peers · median 0.0%
Return on Equity (ROE)
-49.5%
33rd pct of 239 Healthcare peers · median -20.2%

Year-over-Year Growth

Revenue Growth (YoY)
+267.6%
96th pct of 242 Healthcare peers · median +5.3%
EPS Growth (YoY)
+38.5%
65th pct of 208 Healthcare peers · median +15.9%

Financial Position

Current Ratio
9.03x
82nd pct of 236 Healthcare peers · median 2.39x

Market Sentiment

Short Squeeze RiskLow

Dividend & Income Analysisi10-Year historical income simulation on a $10,000 initial investment, cumulative dividend income generated, average yield on cost, and annual payout table.

Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators: distance from 50/200-Day SMA, 52-Week High proximity, Golden Cross trend signal, RSI momentum gauge, Fibonacci retracement levels, and Beta (market sensitivity).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-0.8%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+30.3%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
11.1% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
2.24
Market sensitivity coefficient
Trend SignalGolden Cross & Death CrossTechnical chart patterns that occur when a short-term moving average crosses over a long-term moving average.Click for full definition →
✦ Golden Cross
Bullish — 50 SMA above 200 SMA
RSI (14-Day)Relative Strength Index (RSI)A momentum oscillator that measures the speed and change of price movements to identify overbought or oversold conditions.Click for full definition →
32
OversoldNeutralOverbought
Neutral
Fibonacci LevelsFibonacci RetracementTechnical levels based on mathematical ratios that indicate potential support and resistance areas.Click for full definition →
38.2% retracement+12.0%
50.0% retracement+21.8%
61.8% retracement+33.5%
% distance of current price from each 52-week Fibonacci support level.

In-Depth Analysis

ACOG.US — 10-Year Return & Risk Profile

Alpha Cognition Inc (ACOG.US) has delivered strong annualized growth of 16.2% over the last 10 years. A $10,000 investment at the start of the period would have grown to approximately $44,727, representing a total return of 347%. Over this period, ACOG.US generated positive annual returns in 10 out of 10 calendar years (100%).

The best single calendar year for ACOG.US was 2026, with a return of +34.0%. The worst year was 2025, when the asset declined 10.4%. This spread between best and worst year is a useful indicator of the range of outcomes an investor might have experienced in a given 12-month window.

The asset's Sharpe ratio of 0.51 is considered acceptable on a risk-adjusted basis. The Sharpe ratio measures return earned above the risk-free rate per unit of total volatility — a higher reading indicates more efficient return generation relative to the risk taken. Investors focused on risk-adjusted outcomes should weigh this figure alongside absolute CAGR when making allocation decisions.

ACOG.US — Drawdown, Volatility & Downside Risk

ACOG.US's annualized volatility of 66.7% is classified as high relative to the long-run US equity benchmark of approximately 15%. This above-average volatility means investors in ACOG.US have historically experienced larger day-to-day price swings than the broader market, which requires a higher tolerance for short-term portfolio fluctuations.

The asset's maximum peak-to-trough decline over the study period was 48.1% — a severe bear-market collapse. Drawdown magnitude is a critical consideration for investors who may need to liquidate positions during market stress, as a larger decline requires proportionally greater subsequent gains to recover to the prior peak. A 48% drawdown, for example, requires a 93% gain just to break even.

When evaluating ACOG.US for inclusion in a diversified US portfolio, it is important to note that historical volatility and drawdown metrics are backward-looking. They capture the risk environment of the past 10 years, which included the COVID-19 market crash (2020), the 2022 Federal Reserve rate hike cycle, and various geopolitical disruptions. Future risk may differ materially, particularly in response to structural changes in US monetary policy, sector regulation, or macroeconomic regime shifts.

ACOG.US — Macroeconomic Factor Risk Exposure

The macroeconomic factor model attributes 58.7% of ACOG.US's return variance to High-Yield Corporate Credit. This means that when High-Yield Corporate Credit rises or falls sharply, ACOG.US tends to move in the same direction with meaningful magnitude. Investors who already hold significant exposure to this factor — through other funds or direct equity positions — should be aware of this concentration when sizing their ACOG.US allocation.

The second-largest macro driver is US Quality Factor, contributing 23.5% of variance. 2.8% of ACOG.US's risk is attributable to idiosyncratic, stock-specific factors that are uncorrelated with the broader macro drivers. A higher idiosyncratic share generally indicates that the fund's performance is more dependent on the security selection or holdings composition of the individual underlying assets, rather than broad market forces.

For US investors building a diversified multi-asset portfolio, understanding ACOG.US's factor exposures helps assess its marginal contribution to overall portfolio risk. Adding ACOG.US alongside assets with low correlation to High-Yield Corporate Credit — such as US Treasury bonds, commodities, or assets with significant developed-market ex-US exposure — can reduce the overall portfolio's sensitivity to any single macroeconomic theme.

Compare this AssetiRun a head-to-head backtest and risk analysis against similar assets.

Frequently Asked Questions & Methodology

Is Alpha Cognition Inc a high-risk investment?

Alpha Cognition Inc (ACOG.US) has an annualized volatility of 206.7% and experienced a maximum drawdown of 48.1% over the last 10 years. Its primary macro risk driver is HYG.US.

What is the 10-year return of ACOG.US?

Over the past 10 years, ACOG.US has generated a Compound Annual Growth Rate (CAGR) of 16.2%. A $10,000 investment would have grown to approximately $44,727. It has had a positive return in 100% of calendar years.

What is ACOG.US's Sharpe ratio?

ACOG.US has a Sharpe ratio of 0.51 and a Sortino ratio of 1.25 over the 10-year period. The Sharpe ratio measures risk-adjusted return — how much excess return is earned per unit of volatility. A reading below 1.0 suggests investors were not fully compensated on a risk-adjusted basis.

What is ACOG.US's dividend yield?

ACOG.US does not pay a meaningful dividend. Its returns are driven primarily by price appreciation. Investors seeking regular income may wish to consider dividend-focused alternatives.

Is ACOG.US above its 200-day moving average?

ACOG.US is currently above its 200-day moving average by 30.3%. The current trend signal is: Bullish — 50 SMA above 200 SMA. The 200-day SMA is a widely used long-term trend filter — assets trading above it tend to exhibit positive price momentum.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Alpha Cognition Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest